dactinomycin and Morbid Obesity

dactinomycin has been researched along with Morbid Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahouth, SW; Fain, JN; Madan, AK	1

Other Studies

1 other study(ies) available for dactinomycin and Morbid Obesity

Article	Year
Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochemical pharmacology, 2005, May-01, Volume: 69, Issue:9 Topics: Adipocytes; Adipose Tissue; Culture Techniques; Dactinomycin; Etanercept; Female; Humans; Immunoglobulin G; Interleukin-1; Interleukin-6; Interleukin-8; NF-kappa B; Obesity, Morbid; p38 Mitogen-Activated Protein Kinases; Receptors, Tumor Necrosis Factor; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2005

Article

Year

Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue.

Biochemical pharmacology, 2005, May-01, Volume: 69, Issue:9

Topics: Adipocytes; Adipose Tissue; Culture Techniques; Dactinomycin; Etanercept; Female; Humans; Immunoglobulin G; Interleukin-1; Interleukin-6; Interleukin-8; NF-kappa B; Obesity, Morbid; p38 Mitogen-Activated Protein Kinases; Receptors, Tumor Necrosis Factor; RNA, Messenger; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation

2005